HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 185 filers reported holding HORIZON PHARMA PLC in Q4 2017. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $881,000 | +16.7% | 53,200 | 0.0% | 0.00% | – |
| Q1 2018 | $755,000 | -2.8% | 53,200 | 0.0% | 0.00% | – |
| Q4 2017 | $777,000 | +15.1% | 53,200 | 0.0% | 0.00% | – |
| Q3 2017 | $675,000 | -96.6% | 53,200 | -96.8% | 0.00% | -100.0% |
| Q2 2017 | $19,882,000 | +0.3% | 1,674,990 | +24.9% | 0.01% | 0.0% |
| Q1 2017 | $19,824,000 | -6.5% | 1,341,290 | +2.3% | 0.01% | -9.1% |
| Q4 2016 | $21,211,000 | -20.6% | 1,310,990 | -11.1% | 0.01% | -21.4% |
| Q3 2016 | $26,726,000 | +5.5% | 1,474,100 | -4.2% | 0.01% | 0.0% |
| Q2 2016 | $25,340,000 | +19.8% | 1,538,570 | +20.5% | 0.01% | +27.3% |
| Q1 2016 | $21,155,000 | +3952.7% | 1,276,730 | +5195.9% | 0.01% | – |
| Q4 2015 | $522,000 | -97.2% | 24,108 | -97.5% | 0.00% | -100.0% |
| Q3 2015 | $18,756,000 | – | 946,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 3,018,021 | $44,063,000 | 7.20% |
| SCOPIA CAPITAL MANAGEMENT LP | 16,370,364 | $239,007,000 | 4.29% |
| JW Asset Management, LLC | 270,775 | $3,953,000 | 4.21% |
| Avoro Capital Advisors LLC | 4,436,183 | $64,768,000 | 4.20% |
| Rhenman & Partners Asset Management AB | 1,954,912 | $28,542,000 | 3.86% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,341,894 | $92,592,000 | 3.64% |
| Paulson & Co. | 7,870,700 | $114,912,000 | 2.24% |
| Proxima Capital Management, LLC | 260,000 | $3,796,000 | 2.20% |
| KOPP INVESTMENT ADVISORS LLC | 105,126 | $1,535,000 | 1.54% |
| ARMISTICE CAPITAL, LLC | 1,000,000 | $14,600,000 | 1.46% |